Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 6, 2004
Grant Date -
Nov 13, 2003
app pub date -
May 10, 2002
filing date -
May 10, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method is described for treating hypercholesterolemic atherosclerosis or for reducing total cholesterol while raising high-density lipoportoein cholesterol. It involves administering to a patient a substantially pure complex derived from flaxseed and containing secoisolariciresinol diglucoside (SDG), cinnamic acid glucosides and hydroxymethyl glutaric acid.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully